Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
NCT00002575
Colorectal / Colon / Rectal Cancer
Closed
Heidi Nelson, MD
Gastrointestinal Cancer
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
NCT01515787
Colorectal / Colon / Rectal Cancer
Closed
Deborah Schrag, MD
Breast Cancer
Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
NCT05207709
Breast Cancer
Closed
Lisa A Carey, MD
Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer
NCT00016952
Colorectal / Colon / Rectal Cancer
Closed
Henry C. Pitot, MD
Breast Cancer
Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741
NCT00991263
Breast Cancer
Closed
Matthew J. Ellis, MD, PhD, FRCP
Genitourinary Cancer
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00052845
Prostate Cancer
Closed
Nancy Dawson, MD
Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies
NCT00897663
Brain / Central Nervous System Cancer
Closed
Jann Sarkaria, MD
Gastrointestinal Cancer
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
NCT00311610
Colorectal / Colon / Rectal Cancer
Closed
Allyson Ocean, MD
Breast Cancer
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
NCT05633654
Breast Cancer
Open
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
NCT00023686
Prostate Cancer
Closed
Paul H. Lange, MD

Research in Action

See how Alliance trials are advancing treatment

Alliance News